# Concr

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/concr

- Industry: Software
- Headquarters: London, UK
- Website: www.concr.co
- Total disclosed funding: $2M
- Latest round: Seed (Mar 17, 2023)
- Investors on record: 4

## About

Based in London, UK, and founded in 2018, Concr Limited operates as a healthcare technology firm. The company was founded by its CEO, Matt Foster, CTO, Matthew Griffiths, and CSO, Uzma Asghar. In March 2023, Concr Limited raised GBP 1.22 million in seed funding, co-led by SyndicateRoom, Cambridge Enterprise, Cambridge Angels Group, and R42.

Concr provides FarrSight, which is an online platform that analyzes data sets and stores cancer-related data in a single location that can be used for drug development and patient treatment. The company leverages statistical modeling and machine learning algorithms to analyze and integrate data from diverse sources, including in-vitro models and cancer biopsies.

The company plans to use the funds raised in March 2023 to support further product development and expand its portfolio in the pharmaceutical line.

## Funding rounds

- Seed, Mar 17, 2023, $2M — Cambridge Enterprise, Cambridge Angels Group, SyndicateRoom, R42

## Investors

- Cambridge Enterprise — Seed
- Cambridge Angels Group — Seed
- SyndicateRoom (https://capitalatlas.ai/funds/syndicateroom) — Seed
- R42 (https://capitalatlas.ai/funds/r42) — Seed